Summary
This filing is an amendment to Johnson & Johnson's (JNJ) 2001 Form 10-K, filed in June 2002, primarily for administrative and disclosure purposes. While it doesn't introduce new material financial performance data for the fiscal year ending December 30, 2001, it confirms the company has met its filing obligations for the preceding 12 months and is subject to such requirements for the past 90 days. The filing also provides an updated market capitalization figure as of February 26, 2002, valuing the company at approximately $181 billion based on its outstanding common stock. Investors can view this as a procedural update rather than a source of new strategic or operational insights. The core financial and operational details for the 2001 fiscal year would be found in the original 10-K filing. This amendment serves to ensure all regulatory requirements are met, including the potential disclosure of delinquent filer information, which is noted as not being contained herein. The outstanding common stock count as of February 26, 2002, is also detailed.
Key Highlights
- 1Amendment to the 2001 Form 10-K filed on June 26, 2002.
- 2Confirms JNJ has filed all required reports for the preceding 12 months and is current for the past 90 days.
- 3Aggregate market value of non-affiliate stock was approximately $181 billion as of February 26, 2002.
- 4Total outstanding shares of Common Stock were 3,047,147,480 as of February 26, 2002.
- 5Indicates that delinquent filer information (Item 405) is not contained in this amendment.
- 6Incorporates by reference portions of the 2001 Annual Report to Shareowners for Parts I and II, and the 2002 Proxy Statement for Part III.